164 related articles for article (PubMed ID: 35362843)
1. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer.
Wang K; Hao Z; Fu X; Li W; Jiao A; Hua X
Mol Cell Biochem; 2022 Jul; 477(7):1947-1957. PubMed ID: 35362843
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
Han G; Zhang X; Liu P; Yu Q; Li Z; Yu Q; Wei X
Int J Oncol; 2018 Nov; 53(5):2056-2066. PubMed ID: 30132513
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
Chen R; Fang T; Liu N; Shi X; Wang J; Yu H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238
[TBL] [Abstract][Full Text] [Related]
5. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
7. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma.
Jiangqiao Z; Tao Q; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z; Tianyu W
Biochem Biophys Res Commun; 2019 Mar; 511(1):165-172. PubMed ID: 30777326
[TBL] [Abstract][Full Text] [Related]
8. BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.
Xu J; Guo Z; Yuan S; Li H
Mol Cell Biochem; 2022 May; 477(5):1541-1553. PubMed ID: 35184257
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor tyrosine kinase substrate (IRTKS) promotes the tumorigenesis of pancreatic cancer via PI3K/AKT signaling.
Lu Y; Zhou XY; Zhou CL; Liu J; Yong T; Fan Y; Wang C
Hum Cell; 2022 Nov; 35(6):1885-1899. PubMed ID: 36057038
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
11. Anti-silencing function 1B knockdown suppresses the malignant phenotype of colorectal cancer by inactivating the phosphatidylinositol 3-kinase/AKT pathway.
Yu GH; Gong XF; Peng YY; Qian J
World J Gastrointest Oncol; 2022 Dec; 14(12):2353-2366. PubMed ID: 36568946
[TBL] [Abstract][Full Text] [Related]
12. RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway.
Hua H; Xie H; Zheng J; Lei L; Deng Z; Yu C
Oxid Med Cell Longev; 2023; 2023():1728463. PubMed ID: 36644576
[TBL] [Abstract][Full Text] [Related]
13. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability
Yuan Y; Fan Y; Gao Z; Sun X; Zhang H; Wang Z; Cui Y; Song W; Wang Z; Zhang F; Niu R
Cancer Biol Med; 2020 Aug; 17(3):707-725. PubMed ID: 32944401
[No Abstract] [Full Text] [Related]
14. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway.
Wang K; Li J; Zhou B
Metab Brain Dis; 2022 Feb; 37(2):489-499. PubMed ID: 34792707
[TBL] [Abstract][Full Text] [Related]
15. ASF1B promotes cervical cancer progression through stabilization of CDK9.
Liu X; Song J; Zhang Y; Wang H; Sun H; Feng X; Hou M; Chen G; Tang Q; Ji M
Cell Death Dis; 2020 Aug; 11(8):705. PubMed ID: 32848135
[TBL] [Abstract][Full Text] [Related]
16. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
17. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
[TBL] [Abstract][Full Text] [Related]
18. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway.
Wang W; Xiao L; Pan D; Hu L
Neoplasma; 2022 Mar; 69(2):361-369. PubMed ID: 35103478
[TBL] [Abstract][Full Text] [Related]
19. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP
Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297
[TBL] [Abstract][Full Text] [Related]
20. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
